POLYOMAVIRUS-ASSOCIATED NEPHROPATHY

This adverse event was reported 1193 times

These drugs are most commonly taken by patients reporting POLYOMAVIRUS-ASSOCIATED NEPHROPATHY:

# Drug Count
0 TACROLIMUS 934
1 TACROLIMUS CAPSULES 836
2 MYCOPHENOLATE MOFETIL 736
3 PREDNISONE 397
4 PREDNISOLONE 318
5 METHYLPREDNISOLONE 253
6 BASILIXIMAB 232
7 MYCOPHENOLIC ACID 153
8 VALGANCICLOVIR HYDROCHLORIDE 141
9 VALGANCICLOVIR 137
See all common drugs associated with POLYOMAVIRUS-ASSOCIATED NEPHROPATHY

POLYOMAVIRUS-ASSOCIATED NEPHROPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE 1 0.0714
1 CIDOFOVIR ANHYDROUS 26 0.0354
2 BASILIXIMAB 232 0.0339
3 HUMAN IMMUNOGLOBULIN G 1 0.0286
4 TACROLIMUS CAPSULES 836 0.0150
5 VALGANCICLOVIR HYDROCHLORIDE 141 0.0145
6 TACROLIMUS 934 0.0111
7 MYCOPHENOLATE MOFETIL 736 0.0109
8 MYCOPHENOLIC ACID 153 0.0108
9 ANTI-THYMOCYTE GLOBULIN (RABBIT) 59 0.0106
See all drugs enriched for association with POLYOMAVIRUS-ASSOCIATED NEPHROPATHY